摘要
摘要目的分析表柔比星联合紫杉醇治疗三阴性乳腺癌的效果.方法选取我院收治的４０例三阴性乳腺癌患者作为观察对象,采用随机分组的方式将４０例三阴性乳腺癌患者分成对照组与实验组.对照组采取表柔比星进行治疗,实验组在对照组的基础上联合紫杉醇进行治疗,观察比较两组三阴性乳腺癌患者的临床疗效以及不良反应发生率.结果两组三阴性乳腺癌患者临床疗效的比较结果存在显著差异,p＜０．０５,差异有统计学意义;但两组三阴性乳腺癌患者不良反应发生率的比较结果不存在显著差异,P＞０．０５,统计学不具有意义.结论对三阴性乳腺癌患者采取表柔比星联合紫杉醇进行治疗效果显著.关键词表柔比星;紫杉醇;三阴性乳腺癌;效果Theeffectofepirubicinpluspaclitaxelinthetreatmentoftriple－negativebreastcancerexperienceYinZhiyuWeicountryinhebeiprovincepeople??shospitaloutＧsidea０５６８００AbstractObjectiveToanalyzetheepirubicinpluspaclitaxelinthetreatmentoftriple－negativebreastcancerineffect．MethodsInourhospital,４０casesoftriple－negativebreastcancerpatientsasanobjectofobservation,usingtherandomizedmanner４０casesoftriplenegativebreastcancerpatientsweredividedintoacontrolgroupandexperimentalgroup．Thecontrolgrouptakingepirubicintreatment,theexperimentalgroupincombinationwithpaclitaxelfortreatmentonthebasisofthecontrolgroup,theclinicalefficacybetweenthetwogroupsofpatientswithtriple－negativebreastcancerandincidenceofadversereactions．ResultsComparisonoftheresultsoftheexistenceoftwosetsoftriple－negativebreastcancerpatientswithclinicallysignificantdifferenceinefficacy,p＜０．０５,thedifferＧencewasstatisticallysignificant;buttheresultofthecomparisongroupsofpatientswithtriple－negativebreastcancerincidenceofadversereactionsthereisnosignificantdifference,P＞０．０５Statisticalsignificancedoesnothave．ConclusionTriple－negativebreastcancerpatientstotakeepirubicinpluspaclitaxelfortreatＧment,theeffectissignificant．Keywordsepirubicin;paclitaxel;triple－negativebreastcancer;effect中图分类号R２文献标识码B文章编号１００８－６３１５(２０１５)１２－０２６２－０２
出版日期
2015年12月22日（中国期刊网平台首次上网日期，不代表论文的发表时间）
